S-Adenosyl-l-homocysteine Hydrolase Inactivation Curtails Ovalbumin-Induced Immune Responses-Reference-Cited by-同舟云学术

S-Adenosyl-l-homocysteine Hydrolase Inactivation Curtails Ovalbumin-Induced Immune Responses

Published:2005-12-02 Issue:3 Volume:316 Page:1229-1237
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Fu Yun-Feng,Wang Jun-Xia,Zhao Yang,Yang Yang,Tang Wei,Ni Jia,Zhu Yi-Na,Zhou Ru,He Pei-Lan,Li Chuan,Li Xiao-Yu,Yang Yi-Fu,Lawson Brian R.,Zuo Jian-Ping

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference31 articles.

1. Functional diversity of helper T lymphocytes

2. Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or Hypercholesterolemia

3. LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial Cells

4. In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen.

5. Stimulation of the phosphatidyl-inositol pathway can induce T-cell activation

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA methylation of AHCY may increase the risk of ischemic stroke;Bosnian Journal of Basic Medical Sciences;2020-02-04

2. DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models;Arthritis Research & Therapy;2019-12

3. Assay development for determination of DZ2002, a new reversible SAHH inhibitor, and its acid metabolite DZA in blood and application to rat pharmacokinetic study;Journal of Pharmaceutical Analysis;2019-02

4. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17;Pharmacological Research;2018-03

5. Targeting methionine cycle as a potential therapeutic strategy for immune disorders;Expert Opinion on Therapeutic Targets;2017-08-23